Corteria Pharmaceuticals
Corteria Pharmaceuticals is a Healthcare & Life Sciences startup based in Israel, most recent round Series A, 1 tracked investor.
About Corteria Pharmaceuticals
Corteria Pharmaceuticals is a company founded in 2021 headquartered in Israel. Its most recent tracked round is Series A. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Corteria Pharmaceuticals is a privately held biotechnology company developing first-in-class drugs, focused on interceptive therapies for worsening and acute decompensated heart failure and related subpopulations such as sarcopenia and obesity. The company emphasizes innovative patient stratification and target selection to address high unmet medical needs in cardiovascular indications.
Explore Corteria Pharmaceuticals's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.